MOBI has their Mao platform for distribution...seems things are looking very good for them moving forward.
excellent consolidation around mid 8s after the earnings jump. Next jump up to over $10 coming in Sept with partnership news.
don't say I didn't warn you krill66.
Vietnam, Malaysia, Thailand, Singapore, Korea ? Japan ?
someone knows something coming up with MOBI....
During the second quarter, our deep collaborations with China Mobile and China Unicom, enabled us to expand strong penetration into Beijing, Foshan and a few major cities in Guangdong Province.
As of June 30, 2014, Sky-mobi services were available at over 40,000 telecom stores in China. In addition, in May, we established two major strategic partnerships with Tencent and Xiaomi, bringing our distribution network to over 100 channels.
As of June 30 of this year, we have [tied] [ph] up with over 40,000 telecom stores nationwide. Since we have started partnership with the above two regions, we believe our penetration rates will achieve a stronger growth in the second half year.
We strongly believe in the near future say timeframe 12 months, Sky-Mobi will be the number and first choice all of the global game developers' choice in China to get their light game distribute and published.
I think the second question you mentioned are recent expansion of our business in Southeast Asia. I think Southeast Asia is very, very attractive market to us. In general, Southeast Asia, has more than 554 million population with 70 to 75 penetration rate.
the growth has just STARTED to ramp up. Just look at the results announced. The stock is consolidating after the 24% run up. Next leg up coming IN SEPT.
Growth over next 12 months is going to be massive compared to last 12...imagine PPS next 12 months if it shot up 130% last 12 months. Even with this run up, stock is still trading at DEEP discount to peers on P/E and P/S.
now it is at 8 AFTER company confirmed smartphones picking up big, revenues picking up big. We are looking at 100% YOY moving forward. The turnaround is here.
Citron is going to give another thumbs up any day now. Stock is very undervalued at $8.
into single user games. MOBI is expanding big into singapore, malaysia, vietnam etc. Time is to buy now when stock is still under $10.
Maybe QIHU will buy them when they announce earnings next week.
very undervalued given the growth spike they just announced. This can double and still be undervalued compared to YY, QIHU, BIDU valuations.
so it is not 'modest'....estimates will start coming down Monday for next 2-3 qtrs.
I really don't imagine there will be a line to buy a $80,000 car. I see a couple of model S on the road in California, but otside CA there are very very few electic cars. This is not an apple product, that sells for $200-$400. Stock is way overvalued.
This is not good news for TSLA stockholders..maybe good news for existing TSLA owners.
HIFU is definitely taking off in Canada, Europe, Asia. Go read their last qtr statement.
Stock price already factored in US FDA loss (but it may still get it. FDA does not need to agree with panel). Stock is undervalued now and will rise with earnings.
this is NOT going bankcrupt. It has market cap LOWER than its FY14 revenue. Europe/Asia/Canada still very big on this. Time to buy is NOW after this massive selloff.
agree...I somehow feel if this was a US company it would have got it. Their CEO even shifted operations to US to prepare for the post approval work. Its just bizzare that something that is approved in Europe for so long, that got reimbursement in France got rejected ALL votes in the panel.
stock will rally tomorrow. AH volume was only 150k...tomorrow total volume will exceed 3 mil.
this stock is a yoyo....thank Yellen for the cheap shares.
think there is going to be some profit taking next few days on EDAP. Not chasing here...
I don't think so...market cap is already at $148M (its not $130M as shown in yahoo finance). July 30th is just panel recommendation, and stock is already up from mid 3s due to July 30th event.
I agree once FDA approval does come, it may go up to $7-8. But that would be Q4FY14...who knows with FDA.
July 30th is NOT FDA approval. Plus FDA does not need to follow the recommendation either. Look it up.